What Is a Semaglutide at Home Kit — and What Should You Expect?

What does a licensed semaglutide home kit actually contain?

When a UK pharmacy dispenses Wegovy for home use, what arrives is a pre-filled, single-use injection pen made by Novo Nordisk. The pen contains one month's treatment (four weekly doses) at your current prescribed strength. You do not need to draw up a dose, attach a needle from a separate pack, or reconstitute anything. The mechanism is built in.

What you supply yourself is straightforward: a clean injection site (abdomen, thigh, or upper arm), an alcohol swab if you prefer one, and a sharps container for safe disposal once the pen is empty. Some people wonder whether a "semaglutide home kit" means a blood test or monitoring device comes with it. It does not. The pen is the medicine; clinical monitoring happens through your prescriber's aftercare process, not via a piece of hardware in the box.

The NHS medicines page for semaglutide describes the injection technique clearly and is worth reading alongside the leaflet that comes with your prescription. Storage matters too: the pen lives in the fridge at 2–8°C; the exact window during which it can be kept at room temperature is stated in the Patient Information Leaflet, and that is the reference to follow, not any number quoted online.

Is a "semaglutide ELISA kit" or "semaglutide test kit" the same thing?

No, and the distinction is worth knowing. A semaglutide ELISA kit is a laboratory assay used in research settings to measure semaglutide concentrations in biological samples. A semaglutide test kit in that sense is scientific equipment, not a patient product. Neither is relevant to someone using Wegovy for weight management at home.

If you have seen references to a "semaglutide at home kit" that sounds more like a testing or compounding product, it is worth being cautious. Compounded semaglutide is not licensed by the MHRA for weight management, and the MHRA has warned publicly about fake and unlicensed weight-loss pens sold online. The only legitimate route to semaglutide for weight loss in the UK is a licensed product (Wegovy) dispensed after clinical assessment through a pharmacy you can verify on the GPhC register.

If a product is marketed as a semaglutide kit available without a prescription, that is a serious red flag. Reporting suspect sellers is straightforward via the MHRA's Yellow Card scheme.

Who can be prescribed semaglutide for home use in the UK?

Wegovy is licensed for adults with a BMI of 30 or above, or 27 and above where at least one weight-related condition is present, for example, high blood pressure, raised cholesterol, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. BMI alone does not determine suitability; a prescriber looks at the full picture, including medical history and any medicines you already take.

On the NHS, access follows a phased rollout tied to specific eligibility criteria, and waiting times vary considerably by area. Many people explore the private route through a regulated pharmacy as an alternative, where no referral or waiting list is required, though clinical assessment is still central to the process. NICE's appraisal of semaglutide for weight management, TA875, sets the framework for NHS use, which includes a maximum treatment duration of two years within a specialist service.

Private prescribing operates within the same licensed eligibility criteria. A prescriber decides suitability, and that decision is reviewed again before any repeat supply. If you are still weighing up your options, our guide to using semaglutide at home walks through the process alongside the broader background on semaglutide.

What side effects should someone using semaglutide at home know about?

The most common effects are gastrointestinal: nausea, loose stools, constipation, indigestion, and sometimes vomiting, particularly in the first few weeks or after a dose increase. For most people these are manageable and ease off as the body adjusts. Eating smaller portions, avoiding very fatty meals, and staying well hydrated all help. There is a separate page on managing stomach upset on Wegovy if you want more detail on practical strategies.

Two situations warrant prompt medical attention rather than waiting it out. First, severe stomach pain that radiates to the back, with or without vomiting, can indicate pancreatitis, the MHRA issued a specific Drug Safety Update for GLP-1 medicines on this in January 2026, and it should not be dismissed as ordinary nausea. Second, signs of a serious allergic reaction (swelling, difficulty breathing, rapid heartbeat) need emergency care. Your Patient Information Leaflet lists all the symptoms to watch for; read it before your first injection, not after.

Wegovy is not suitable during pregnancy, while breastfeeding, or for anyone trying to conceive. It is not licensed for under-18s. If you take oral contraceptives, the interaction picture differs slightly between semaglutide and tirzepatide, your prescriber can advise based on your specific medicines. The FAQs page covers several common questions on this.